ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
88.165
0.00%
Bitcoin
63,537.88
0.20%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. ENDRA Life Sciences Inc (NDRA) Quote

ENDRA Life Sciences Inc

ENDRA Life Sciences Inc (NDRA)

NASDAQ
0.2525
0.01
(4.12%)
Closed April 28 4:00PM
Delayed by 15 minutes
0.2525
0.00
(0.00%)
After Hours: 5:15PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.2525
Bid
0.2476
Ask
0.99
Volume
11,104
0.2422 Day's Range 0.257299
0.221 52 Week Range 2.77
Market Cap
2.114M
Previous Close
0.2425
Open
0.252
Last Trade
5
@
0.2476
Last Trade Time
Financial Volume
$ 2,807
VWAP
0.252802
Average Volume (3m)
181,464
Shares Outstanding
8,454,922
Dividend Yield
-
PE Ratio
-0.21
Earnings Per Share (EPS)
-1.19
Revenue
-
Net Profit
-10.06M

About ENDRA Life Sciences Inc

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAE... ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures. Show more

Sector
Electromedical Apparatus
Industry
Electromedical Apparatus
Website
www.endrainc.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
ENDRA Life Sciences Inc is listed in the Electromedical Apparatus sector of the NASDAQ with ticker NDRA. The last closing price for ENDRA Life Sciences was $0.24. Over the last year, ENDRA Life Sciences shares have traded in a share price range of $ 0.221 to $ 2.77.

ENDRA Life Sciences currently has 8,454,922 shares outstanding. The market capitalization of ENDRA Life Sciences is $2.11 million. ENDRA Life Sciences has a price to earnings ratio (PE ratio) of -0.21.

NDRA Latest News

More News

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Conference call begins at 4:30 p.m. Eastern time today ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the...

March 28 2024
Business Wire

ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three months and...

March 21 2024
Business Wire

ENDRA Life Sciences Installs First TAEUS System in the UK

King's College Hospital in London Leads UK Introduction of ENDRA Liver System ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that it...

February 27 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

February 23 2024
Edgar (US Regulatory)

New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System

Code Complements Important Advancements by the Pharmaceutical Industry and Revised Medical Association Guidelines ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced...

February 21 2024
Business Wire

ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe

Global Intellectual Property Portfolio Expands to 74 Issued Patents ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the issuance of...

February 14 2024
Business Wire

Form 424B3 - Prospectus [Rule 424(b)(3)]

December 29 2023
Edgar (US Regulatory)

ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology

Intellectual Property Portfolio Now Stands at 71 Globally Issued Patents ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the...

November 29 2023
Business Wire

ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will be participating in The Benchmark Company’s 12th Annual...

November 27 2023
Business Wire

ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

Conference call begins at 4:30 p.m. Eastern time today ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the...

November 14 2023
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00753.06122448980.2450.281750.23397260.25063733CS
4-0.1965-43.76391982180.4490.50.2212037690.3455778CS
12-0.7575-751.011.280.2211814640.7541133CS
26-0.7075-73.69791666670.962.770.2211351141.03410225CS
52-1.7075-87.11734693881.962.770.2211133191.13655903CS
156-48.9475-99.486788617949.252.60.22144918511.53072506CS
260-30.1475-99.169407894730.4620.22151921523.7420224CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

NDRA Discussion

View Posts
BoscoLives21 BoscoLives21 1 week ago
Noticed that 181 share sale to the Bid at exactly 4:00:00 — nice paint job! Professional! Hedge fund!!
$NDRA
👍️0
BoscoLives21 BoscoLives21 1 week ago
Clearly it is. Been proven.
$NDRA
👍️0
biotech_researcher biotech_researcher 1 week ago
Unfortunately, it is not accurate enough..
👍️0
BoscoLives21 BoscoLives21 1 week ago
Still here I see! Understandable, ENDRA’s TAEUS system will severely threaten existing and far more expensive technologies, plus remove the need for costly, invasive and dangerous liver biopsies.
$NDRA
👍️0
biotech_researcher biotech_researcher 2 months ago
This should be shut down by now..
👍️0
glenn1919 glenn1919 2 months ago
NDRA..............................................https://stockcharts.com/h-sc/ui?s=NDRA&p=W&b=5&g=0&id=p86431144783
👍️0
biotech_researcher biotech_researcher 2 months ago
Post on 8/14/23:

DeNovo submitted to the FDA finally.

What happened??
👍️0
biotech_researcher biotech_researcher 4 months ago
Stinky..
👍️0
derkampfer derkampfer 8 months ago
Finally
👍️0
dndodd dndodd 8 months ago
DeNovo submitted to the FDA finally.
👍️0
biotech_researcher biotech_researcher 11 months ago
Correct…Unless you can offer a good price on a Rolex to the CEO….
👍️0
jmw02 jmw02 1 year ago
Is this stock down and out for the count?
👍️0
dndodd dndodd 1 year ago
LOL I still think nothing happens until they are FDA approved and they have sales.
👍️0
biotech_researcher biotech_researcher 1 year ago
GEHC is now trading as an independent company from GE. Now, they can make their move on NDRA, Rolexes and all…
👍️0
dndodd dndodd 1 year ago
No sorry not nearly as much as you.
👍️0
OR Nurse OR Nurse 1 year ago
This is not a Titan message board. You are still confused.
👍️0
OR Nurse OR Nurse 1 year ago
Looks like it is down premarket as well. Ride it down. Hold on tight. Yeehaw!
👍️0
dndodd dndodd 1 year ago
Yes but you would not have come if you hadn’t disliked my post on Tian no matter how true it is.
👍️0
biotech_researcher biotech_researcher 1 year ago
Unfortunately, with only 3 million shares outstanding, and a market cap of only $13 million, their patents aren’t as valued as you think..
👍️0
dndodd dndodd 1 year ago
Unfortunately the stock never hit the levels pre RS.
👍️0
OR Nurse OR Nurse 1 year ago
This is not a Titan board. I think you are confused. Sort of like your investment here. As a moderator you should be aware of the fact that you have to stick to the subject matter.
👍️0
biotech_researcher biotech_researcher 1 year ago
I expect he fell in love with the stock. I pounded the table for him to sell it in the $5-$7 range, but that made him more angry.. I expect when the CEO showed his collection of Rolexes on social media, that was the ticket that hooked him.. Rode it all the way down…
👍️0
dndodd dndodd 1 year ago
Not as painful as TITAN. But any day now they will file their DeNovo and the stock will pop. Then they might actually sell something in Europe and that will cause another pop. Or they could publish data.
At least they haven’t given there patients away yet.
Thanks for visiting and best of luck with Titan.
👍️0
OR Nurse OR Nurse 1 year ago
Boy. That must have been painful.
👍️0
OR Nurse OR Nurse 1 year ago
I see.
👍️0
OR Nurse OR Nurse 1 year ago
Wow. Looks like this stock keeps dropping. Is this a good time ot get in or will it drop further?
👍️0
OR Nurse OR Nurse 1 year ago
Looks like it didn't last since you posted this comment. pps is lower now, right?
👍️0
OR Nurse OR Nurse 1 year ago
Wow. This stock sure has dropped in the last year. Glad I didn't get into a year ago.
👍️0
dndodd dndodd 1 year ago
Yes they are.
👍️0
biotech_researcher biotech_researcher 1 year ago
1 for 20 reverse splits are brutal..
👍️0
Adrock Adrock 1 year ago
You won!!!!

Congratulations
👍️0
dndodd dndodd 1 year ago
Yes it beat TItan to that number but I think Titan may follow soon. Unless there is miracle
👍️0
Adrock Adrock 1 year ago
.2176 really??
👍️0
AKATITUS AKATITUS 1 year ago
Or is a head fake like the O/S raise.
👍️0
biotech_researcher biotech_researcher 1 year ago
Reverse Split pressure? Is it 10 for 1, 30 for 1, or 100 for 1??
👍️0
dndodd dndodd 2 years ago
Because those sec filings were not sent to investors unless they signed up for SEC notifications. I have asked IR to look into it. Maybe they will.
👍️0
AKATITUS AKATITUS 2 years ago
Don t know. Was wondering why it didn t drop when they anounced the rs weeks ago.
👍️0
dndodd dndodd 2 years ago
Maybe someone or somebody’s opened there email and didn’t like the proxies for the RS.
👍️0
Tonyboons33 Tonyboons33 2 years ago
What's happening today you think? High volume, large drop. Single seller?
👍️0
dndodd dndodd 2 years ago
In this bear market they have to be prepared for the worst.
👍️0
jmw02 jmw02 2 years ago
No comments about the proposed reverse split?
👍️0
dndodd dndodd 2 years ago
Link please because I don't see any PR about 25 more scans?
👍️0
biotech_researcher biotech_researcher 2 years ago
Now they are measuring 25 more scans as significant enough to post PR on it. Fatty liver is exploding and that is all they got???
👍️0
dndodd dndodd 2 years ago
Insider buying is always nice. Especially when one is the the inventor of the technology.
👍️0
dndodd dndodd 2 years ago
Coming to a clinician near you soon.
👍️0
biotech_researcher biotech_researcher 2 years ago
What happened to the milestones over the last four years, Will??
👍️0
dndodd dndodd 2 years ago
Enough to get past some significant milestones
👍️0
biotech_researcher biotech_researcher 2 years ago
$11 million of cash left. Burned $3.6 million in Q2. Math question, how many quarters left?
👍️0
biotech_researcher biotech_researcher 2 years ago
Installed TAEUS system at a fourth clinical evaluation site, in the U.S. Year-to-date, more than 50 TAEUS scans have been performed on study participants, a 25% increase from May 2022, and ENDRA remains on track for at least 200 patients to be scanned by year end. These clinical evaluation sites are being used to generate data to support the commercialization of the TAEUS system, and a subset of the data will be used to support ENDRA's submission of its De Novo request.

Oh brother. 50 scans…
👍️0
biotech_researcher biotech_researcher 2 years ago
Could be a reason for that…just saying…
👍️0

Your Recent History

NASDAQ
NDRA
ENDRA Life Sciences
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved